LivaNova (NASDAQ:LIVN – Get Free Report) had its price target raised by Mizuho from $75.00 to $80.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the stock. Mizuho’s price objective suggests a potential upside of 27.75% from the company’s current price. A number of other […]
Related Keywords
Robertw Baird , , Needham Company , Ameriprise Financial Inc , Norges Bank , Barclays , Primecap Management Co , Healthcare Of Ontario Pension Plan Trust Fund , Loomis Sayles Co , Livanova Company Profile , Get Free Report , Ontario Pension Plan Trust Fund , Advanced Circulatory Support , Livanova Daily , Livanova , Nasdaq Livn , Livn , Medical , Boost Price Target , Mizuho ,
vimarsana.com © 2020. All Rights Reserved.